Bionano prices $80.0 million financing in convertible notes and warrants, announces preliminary q3 2023 results, and implements streamlined operational plan

San diego, oct. 11, 2023 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today reported certain business updates and unaudited preliminary financial results for the third quarter ended september 30, 2023.

BNGO Ratings Summary

BNGO Quant Ranking